| Literature DB >> 16519706 |
R H H Bemelmans1, D W van Toorn, L van Leeuwen, C G Schaar.
Abstract
Long-term complete remission in IgD multiple myeloma (MM) is rare. This case report describes a patient with a stage IIIB IgD-MM, who was treated with conventional melphalan and prednisone chemotherapy. The monoclonal protein disappeared after four cycles and therapy was discontinued after 14 cycles. Re-evaluation after a follow up of more than 8 years demonstrates a continuing complete remission suggesting a cure. This is remarkable, considering that several adverse prognostic factors were present. In addition a concise review on IgD-MM is given.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16519706 DOI： 10.1111/j.1600-0609.2005.00600.x
Source DB: PubMed Journal: Eur J Haematol ISSN： 0902-4441 Impact factor: 2.997